These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26337435)

  • 1. Screening attendance, age group and diabetic retinopathy level at first screen.
    Scanlon PH; Stratton IM; Leese GP; Bachmann MO; Land M; Jones C; Ferguson B;
    Diabet Med; 2016 Jul; 33(7):904-11. PubMed ID: 26337435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.
    Scanlon PH; Stratton IM; Bachmann MO; Jones C; Leese GP;
    Diabet Med; 2016 Dec; 33(12):1655-1658. PubMed ID: 27646856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme.
    Looker HC; Nyangoma SO; Cromie DT; Olson JA; Leese GP; Philip S; Black MW; Doig J; Lee N; Briggs A; Hothersall EJ; Morris AD; Lindsay RS; McKnight JA; Pearson DW; Sattar NA; Wild SH; McKeigue P; Colhoun HM;
    Diabetologia; 2013 Aug; 56(8):1716-25. PubMed ID: 23689796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.
    Ochs A; McGurnaghan S; Black MW; Leese GP; Philip S; Sattar N; Styles C; Wild SH; McKeigue PM; Colhoun HM;
    PLoS Med; 2019 Oct; 16(10):e1002945. PubMed ID: 31622334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.
    Thomas RL; Dunstan F; Luzio SD; Roy Chowdury S; Hale SL; North RV; Gibbins RL; Owens DR
    BMJ; 2012 Feb; 344():e874. PubMed ID: 22362115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study.
    Cheyne CP; Burgess PI; Broadbent DM; García-Fiñana M; Stratton IM; Criddle T; Wang A; Alshukri A; Rahni MM; Vazquez-Arango P; Vora JP; Harding SP;
    Diabet Med; 2021 Sep; 38(9):e14583. PubMed ID: 33830513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.
    Scotland G; McKeigue P; Philip S; Leese GP; Olson JA; Looker HC; Colhoun HM; Javanbakht M
    Diabet Med; 2016 Jul; 33(7):886-95. PubMed ID: 27040994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort.
    Lawrenson JG; Bourmpaki E; Bunce C; Stratton IM; Gardner P; Anderson J;
    Diabet Med; 2021 Apr; 38(4):e14425. PubMed ID: 33064854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study.
    Forster AS; Forbes A; Dodhia H; Connor C; Du Chemin A; Sivaprasad S; Mann S; Gulliford MC
    Diabetologia; 2013 Oct; 56(10):2187-93. PubMed ID: 23793717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.
    Scanlon PH; Aldington SJ; Stratton IM
    Diabet Med; 2014 Apr; 31(4):439-42. PubMed ID: 24093530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland.
    Looker HC; Nyangoma SO; Cromie D; Olson JA; Leese GP; Black M; Doig J; Lee N; Lindsay RS; McKnight JA; Morris AD; Philip S; Sattar N; Wild SH; Colhoun HM; ;
    Diabetologia; 2012 Sep; 55(9):2335-42. PubMed ID: 22688348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme.
    Looker HC; Nyangoma SO; Cromie DT; Olson JA; Leese GP; Black MW; Doig J; Lee N; Lindsay RS; McKnight JA; Morris AD; Pearson DW; Philip S; Wild SH; Colhoun HM; ;
    Br J Ophthalmol; 2014 Jun; 98(6):790-5. PubMed ID: 24599419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2).
    Kelly SR; Loiselle AR; Pandey R; Combes A; Murphy C; Kavanagh H; Fitzpatrick P; Mooney T; Kearney P; Crabb DP; Keegan DJ
    Acta Diabetol; 2021 May; 58(5):643-650. PubMed ID: 33483856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualised screening for diabetic retinopathy: the ISDR study-rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening.
    Broadbent DM; Sampson CJ; Wang A; Howard L; Williams AE; Howlin SU; Appelbe D; Moitt T; Cheyne CP; Rahni MM; Kelly J; Collins J; García-Fiñana M; Stratton IM; James M; Harding SP;
    BMJ Open; 2019 Jun; 9(6):e025788. PubMed ID: 31213445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.
    Broadbent DM; Wang A; Cheyne CP; James M; Lathe J; Stratton IM; Roberts J; Moitt T; Vora JP; Gabbay M; García-Fiñana M; Harding SP;
    Diabetologia; 2021 Jan; 64(1):56-69. PubMed ID: 33146763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service.
    Thomas RL; Dunstan FD; Luzio SD; Chowdhury SR; North RV; Hale SL; Gibbins RL; Owens DR
    Br J Ophthalmol; 2015 Jan; 99(1):64-8. PubMed ID: 25091950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of attendance at diabetic retinopathy screening among people with type 2 diabetes: Secondary analysis of data from primary care.
    O'Keeffe D; Riordan F; Harkins V; Kearney P; Mc Hugh S
    Prim Care Diabetes; 2021 Dec; 15(6):1086-1094. PubMed ID: 34518110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experiment.
    Yeo ST; Edwards RT; Fargher EA; Luzio SD; Thomas RL; Owens DR
    Diabet Med; 2012 Jul; 29(7):869-77. PubMed ID: 22414336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How is the risk of being diagnosed with referable diabetic retinopathy affected by failure to attend diabetes eye screening appointments?
    Virk R; Binns AM; Chambers R; Anderson J
    Eye (Lond); 2021 Feb; 35(2):477-483. PubMed ID: 32317793
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.